Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Chamber Cardio

Explore full profile

Empower cardiology teams to operate in a value-based world, ensuring that providers are compensated for delivering the right care at the right time

Washington DC, United StatesFounded 2022Health Tech & Medtech
Valuation $250–500M Last recorded · 2026
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Chamber Cardio and the history behind them.

About Chamber Cardio

Chamber Cardio, founded in 2022, operates as a technology-enabled healthcare company focused on the cardiology sector. The company was established by George Aloth, a former health plan CEO with experience in value-based care, Dr. Sameer Sheth, a practicing cardiologist and digital health leader, and Dr. Jeffrey De Flavio, a co-founder of Pearl Health. This collective expertise in healthcare administration, clinical cardiology, and value-based business models shaped the company's mission to address challenges faced by cardiologists.

The firm's primary business is to facilitate the transition of cardiology practices to a value-based care (VBC) model, where compensation is tied to patient outcomes rather than the volume of services. It targets cardiology practices and payers as its main clients, aiming to improve health outcomes for individuals with cardiovascular disease, a condition that drives hundreds of billions in annual healthcare spending. Chamber Cardio's business model involves partnering with cardiology practices at no direct cost to them; revenue is generated through shared savings with health plans and by taking on the financial downside risk in value-based contracts.

Chamber Cardio's core offering is a technology platform that integrates with practice workflows to provide real-time data, evidence-based guidelines, and patient insights. This platform is designed to streamline administrative tasks, manage complex patients, and unlock new revenue streams for practices. Beyond the software, the company provides dedicated care teams that act as an extension of the practice to help implement VBC contracts and manage patient panels. It also offers contracting services, leveraging its network of cardiologists to negotiate favorable value-based deals with payers. The company is currently managing patients in the Mid-Atlantic region with plans for national expansion, supported by a March 2024 seed funding round of $8 million led by General Catalyst.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2022
Headquarters
Washington DC, United States
Employees
28
Open positions
11
Dealroom signal
92.2/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Cardiology and cardiovascular, Tech for Hospitals and Clinics, Tech for Medical Professionals, Insurtech Related
Business model
SaaS
Client focus
b2b

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBTDebt Feb 2026 $12M — HSBC Innovation Banking ↗
SERIES AOther financing Feb 2026 $48M $192M General Catalyst · American Family Ventures · Optum Ventures · Company Ventures ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Chamber Cardio website traffic

Latest recorded traffic for Chamber Cardio is 6.5K monthly website visits, up 400% over the last three months. Chamber Cardio's team grew 0% over the past year.

Latest monthly visits6.5K 3-month web change+400% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed5 investors entered at this stage

  • General Catalyst
  • City Light Capital
  • AlleyCorp
  • Company Ventures
  • American Family Ventures

Series A4 investors entered at this stage

  • Frist Cressey Ventures
  • Optum Ventures
  • Black Opal Ventures
  • Healthworx Ventures

Series B and later1 investor entered at this stage

  • HSBC Innovation Banking
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States93.3%
🇨🇦 Canada6.7%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Chamber Cardio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Chamber Cardio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.